Skip to main content
Clinical Trials/CTRI/2014/09/005041
CTRI/2014/09/005041
Recruiting
Phase 4

Comparative study evaluating Quality Of Life of chemotherapy versus Oral TKI in third line and beyond Setting for advanced non-small cell lung cancer

Tata Memorial Hospital0 sites200 target enrollmentTBD

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
Health Condition 1: null- Patients of Advanced Lung cancer
Sponsor
Tata Memorial Hospital
Enrollment
200
Status
Recruiting
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Pms

Investigators

Eligibility Criteria

Inclusion Criteria

  • Inclusion criteria :
  • TKI\-naive patients with documented stage IIIB ( treated with palliative intent) or stage IV NSCLC who have progressed on first and second line chemotherapy regimens
  • .2\. ECOG Performance status (PS) from 0 to 2
  • 3\. Age \>\= 18yrs
  • 4\. Adequate bone marrow tests (absolute neutrophil count \>1500/lL, hemoglobin \> 8 g/dL, and platelet count \>100,000/lL), renal function tests (creatinine \<2 mg/dL), and liver function tests (total bilirubin \<1\.5 times the institutional upper limit of normal \[ULN], aspartate aminotransferase and alanine aminotransferase levels \<2 times the institutional ULN);
  • 5\. Life expectancy \>\= 3 months
  • 6\. Clinically stable brain metastases if any

Exclusion Criteria

  • 1\.Prior therapy with TKI
  • 2\.Patients with EGFR mutation
  • 3\. A second primary tumor
  • 4\. Uncontrolled infection
  • 5\.Uncontrolled co\-morbidities

Outcomes

Primary Outcomes

Not specified

Similar Trials